As of Feb 03, 2025, Thermo Fisher Scientific Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $553.6. This suggests it may be overvalued by (6.8%) compared to its current price of around $593.8, using a WACC of 7.1% and growth rates of 3.0%.
As of Feb 03, 2025, Thermo Fisher Scientific Inc.'s Weighted Average Cost of Capital (WACC) is approximately 7.1%.
As of Feb 03, 2025, Thermo Fisher Scientific Inc.'s Enterprise Value (EV) is approximately $240.3B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.